← Open Payments lookup

TERRI STEELE: Open Payments

NPI 1730108192 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,272 in 57 payments from 13 companies in 2025. Trend: 2023 $1,471 · 2024 $1,605 · 2025 $1,272

Food & beverage: $1,171Education: $101
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$255
ABBVIE INC.20$224
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$179
Vanda Pharmaceuticals Inc.5$147
Teva Pharmaceuticals USA, Inc.3$133
Takeda Pharmaceuticals U.S.A., Inc.3$85
Supernus Pharmaceuticals, Inc.3$64
Axsome Therapeutics, Inc.2$57
Otsuka Pharmaceutical Development & Commercialization, Inc.2$45
Alkermes, Inc.1$24

Products named: REXULTI, VRAYLAR, CAPLYTA, FANAPT, TRINTELLIX, Qelbree, Auvelity, AUSTEDO XR.

Industry payments across AL — which companies pay providers there.